Page last updated: 2024-08-17

medroxyprogesterone acetate and Hepatitis B Virus Infection

medroxyprogesterone acetate has been researched along with Hepatitis B Virus Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Trials

1 trial(s) available for medroxyprogesterone acetate and Hepatitis B Virus Infection

Article	Year
Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. International journal of cancer, 1991, Sep-09, Volume: 49, Issue:2 Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis B; Humans; Kenya; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Thailand; Time Factors	1991

Article

Year

Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

International journal of cancer, 1991, Sep-09, Volume: 49, Issue:2

Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis B; Humans; Kenya; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Thailand; Time Factors

1991